cm512
Small moleculeexperimental
Clinical trial activity
7 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
6
Phase 3
0
Phase 4
0
Earliest trial started Sep 30, 2024 (NCT06553209)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07230483 | Phase 2 | Dec 31, 2025 | Keymed Biosciences Co.Ltd, Peking University |
| NCT07166211 | Phase 2 | Sep 15, 2025 | Keymed Biosciences Co.Ltd |
| NCT07011524 | Phase 2 | Aug 19, 2025 | Keymed Biosciences Co.Ltd |
| NCT06980142 | Phase 2 | Jun 20, 2025 | Fudan University, Keymed Biosciences Co.Ltd |
| NCT06947980 | Phase 2 | Jun 19, 2025 | Keymed Biosciences Co.Ltd, Peking University |
| NCT06930612 | Phase 2 | May 16, 2025 | Capital Medical University, Keymed Biosciences Co.Ltd |
| NCT06553209 | Phase 1 | Sep 30, 2024 | Keymed Biosciences Co.Ltd, Sichuan University |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Keymed Biosciences Co.Ltd | For profit | 7 | 7 | 2 | 2024 |
| Peking University | Academic/Hospital | 2 | 0 | 1 | 2025 |
| Capital Medical University | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Fudan University | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Sichuan University | Academic/Hospital | 1 | 0 | 1 | 2024 |
5 organizations
Page 1 / 1